Veterinary Endocrinology Market

Global Veterinary Endocrinology Market Size, Share & Trends Analysis Report By Route of Administration (Oral and Other routes), By Animal type (Dogs, Cats, and Other Animals), By Application, By Regional Outlook and Forecast, 2024 - 2031

Report Id: KBV-23499 Publication Date: July-2024 Number of Pages: 221
USD 292.1 Million
USD 482.2 Million
Historical Data
2020 to 2022

Market Report Description

The Global Veterinary Endocrinology Market size is expected to reach $482.2 million by 2031, rising at a market growth of 6.6% CAGR during the forecast period.

North America has a significant population of companion animals, including dogs, cats, and other pets. Thus, the North America region acquired 39% revenue share in the market 2023. The high prevalence of pets in households contributes to a larger pool of potential patients requiring specialized veterinary care, including endocrinology services. Pets in North America are often considered family members, leading to greater investments in their health and well-being. Pet owners prioritize preventive healthcare, advanced diagnostics, and specialized treatments, including veterinary endocrinology, to ensure their pets lead healthy and comfortable lives.

Veterinary Endocrinology Market Size - Global Opportunities and Trends Analysis Report 2020-2031

There’s growing awareness among pet owners and veterinarians about various endocrine disorders that affect animals, such as diabetes mellitus, thyroid disorders, adrenal gland disorders, and reproductive hormone imbalances. This awareness leads to more animals being diagnosed and treated for these conditions.

Additionally, the global pet population, including dogs, cats, and exotic pets, continues to increase. This demographic trend directly correlates with a higher incidence of pet health issues, including endocrine disorders such as diabetes mellitus, thyroid disorders, and adrenal gland disorders. Therefore, increasing pet ownership and expenditures on pet healthcare drive the market's growth.

However, veterinary diagnostics and treatments for endocrine disorders can be expensive, especially when multiple diagnostic tests, specialized imaging studies, and ongoing treatment regimens are required. This can create financial constraints for pet owners, leading to hesitation or delay in seeking veterinary care. Thus, the high cost of diagnostic and treatment procedures impedes growth.

Driving and Restraining Factors
Veterinary Endocrinology Market
  • Rising prevalence of endocrine disorders in animals
  • Expansion of veterinary endocrinology services
  • Increasing pet ownership and expenditure on pet healthcare
  • High cost of diagnostic and treatment procedures
  • Complexity of hormonal disorders
  • Growing livestock industry
  • Integration of holistic care approaches
  • Limited access to specialized services
  • Compliance and long-term management

Route of Administration

Based on route of administration, the market is divided into oral and others. In 2023, the oral segment garnered 57.7% revenue share in the market. Oral medications are typically easier to administer than other forms, such as injections or transdermal treatments.

Animal Type Outlook

On the basis of animal type, the market is segmented into dogs, cats, and others. In 2023, the cats segment attained 30.7% revenue share in the market. The cat population, like the dog population, is aging due to advancements in veterinary medicine and nutrition.

Veterinary Endocrinology Market Share and Industry Analysis Report 2023

Application Outlook

Based on application, the market is categorized into pancreatic disorders and others.  In 2023, the pancreatic disorders segment registered 53.2% revenue share in the market. Pancreatic disorders often present with nonspecific clinical signs, making accurate diagnosis challenging.

Free Valuable Insights: Global Veterinary Endocrinology Market size to reach USD 482.2 Million by 2031

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Europe region generated 29.9% revenue share in the market. European veterinarians undergo rigorous training and education, often specializing in specific fields such as endocrinology.

Veterinary Endocrinology Market Report Coverage
Report Attribute Details
Market size value in 2023 USD 292.1 Million
Market size forecast in 2031 USD 482.2 Million
Base Year 2023
Historical Period 2020 to 2022
Forecast Period 2024 to 2031
Revenue Growth Rate CAGR of 6.6% from 2024 to 2031
Number of Pages 221
Number of Tables 328
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives
Segments covered Route of Administration, Animal Type, Application, Region
Country scope
  • North America (US, Canada, Mexico, and Rest of North America)
  • Europe (Germany, UK, France, Russia, Spain, Italy, and Rest of Europe)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific)
  • LAMEA (Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA)
Companies Included Dechra Pharmaceuticals PLC (EQT AB), Elanco Animal Health Incorporated, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Zoetis, Inc., LLOYD, Inc., Covetrus, Inc. (Clayton, Dubilier & Rice, LLC), and Mars, Inc. (Antech Diagnostics, Inc)
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now

List of Key Companies Profiled

  • Dechra Pharmaceuticals PLC (EQT AB)
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Zoetis, Inc.
  • LLOYD, Inc.
  • Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
  • Mars, Inc. (Antech Diagnostics, Inc)

Veterinary Endocrinology Market Report Segmentation

By Route of Administration

  • Oral and
  • Other routes

By Animal Type

  • Dogs,
  • Cats, and
  • Other Animals

By Application

  • Pancreatic Disorders, and
  • Other Disorders

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Malaysia
    • Rest of Asia Pacific
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo